Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1

Status

Unknown 16Completed 6Not yet recruiting 5Recruiting 2Terminated 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 18Gynecologic 5Thoracic 3Sarcoma 1Other solid neoplasm 1NET 1Endocrine 1Breast 1

Conditions

Ovarian Neoplasms 2Ovarian Cancer Recurrent 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 10pembrolizumab 7fluzoparib 7Radiotherapy 6Drug Therapy 6apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4camrelizumab 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × apatinib × Gynecologic × Clear all
NCT06771154 2025-01-13

A-CAPE

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Endometrial Neoplasms

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Anhui Provincial Hospital

Phase 3 Not yet recruiting
51 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT06188455 2024-01-03

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

The First Affiliated Hospital of Xiamen University

Phase 3 Not yet recruiting
37 enrolled
Gynecologic

Ovarian Neoplasms

NCT06102707 2023-10-26

The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

Qilu Hospital of Shandong University

Phase NA Not yet recruiting
50 enrolled
Gynecologic

Ovarian Cancer Recurrent

NCT06081595 2023-10-13

Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

Fudan University

Phase 2 Not yet recruiting
54 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡